Remission with Imatinib mesylate treatment in a patient with initially unresectable dermatofibrosarcoma protuberans - A case report

Oral and Maxillofacial Surgery

Volumn 12, Issue 4, 2008, Pages 209-213

  Lemm, Doreen ^a   Muegge, Lars Olof ^a   Hoeffken, Klaus ^a   Aklan, Talal ^a   Mentzel, Thomas ^b   Thorwarth, Michael ^a   Schultze Mosgau, Stefan ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Dermatopathologische Gemeinschaftspraxis   (Germany)

Author keywords

Dermatofibrosarcoma protuberans; Imatinib; Neoadjuvant; Platelet derived growth factor receptor; Scalp; Surgery; Targeted therapy; Tyrosine kinase inhibitor

Indexed keywords

ANTINEOPLASTIC AGENT; IMATINIB; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; CASE REPORT; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; HUMAN; MIDDLE AGED; PATHOLOGY; SCALP; SKIN TUMOR; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; DERMATOFIBROSARCOMA; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PIPERAZINES; PYRIMIDINES; SCALP; SKIN NEOPLASMS;

EID: 59349103298     PISSN: 18651550     EISSN: 18651569     Source Type: Journal    
DOI: 10.1007/s10006-008-0130-8     Document Type: Article

References (20)

1. Ballo MT, Zagars GK, Pisters P, Pollack A (1998) The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys 40:823-827
2. Barnes L, Coleman JA, Johnson JT (1984) Dermatofibrosarcoma protuberans of the head and neck. Arch Otolaryngol 1103:98-404
3. Bowne WB, Antonescu CR, Leung DHY, Katz SC, Hawkins WG, Woodruff JM, Brennan MF, Lewis JJ (2000) Dermatofibrosarcoma protuberans. A clinicopathologic analysis of patients treated and followed at a single institution. Cancer 88:2711-2720
4. DuBay D, Cimmino V, Lowe L, Johnson TM, Sondak VK (2004) Low recurrence rate after surgery for dermatofibrosarcoma protuberans: A multidisciplinary approach from a single institution. Cancer 100:1008-1016
5. Fiore M, Miceli R, Mussi C (2005) Dermatofibrosarcoma protuberans treated at a single institution: A surgical disease with a high cure rate. J Clin Oncol 23:7669-7675
6. Gloster HM Jr, Harris KR, Roenigk RK (1996) A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol 35:82-7
7. Greco A, Roccato E, Miranda C, Cleris L, Formelli F, Pierotti MA (2001) Growth-inhibitory effect of STI571 on cells transformed by the COL1A/ PDGFB rearrangement. Int J Cancer 92:354-360
8. Kasper B, Lossignol D, Gil T, Flamen P, De Saint Aubain N, Awada A (2006) Imatinib mesylate in a patient with metastatic disease originating from a Dermatofibrosarcoma protuberans of the scalp. Anti-Cancer Drugs 17:1223-1225
9. Kiuru-Kuhlefelt S, El-Rifai W, Fanburg-Smith J, Kere J, Miettinen M, Knuutila S (2001) Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans. Cytogenet Cell Genet 92:192-195
10. Loss L, Zeitouni NC (2005) Management of scalp dermatofibrosarcoma protuberans. Dermatol Surg 31:1428-1433
11. McArthur GA (2006) Dermatofibrosarcoma protuberans: A surgical disease with a molecular savior. Curr Opin Oncol 18:341-346
12. McArthur GA, Demetri GD, van Oosterom A, Heinrich MC, Debiec-Rychter M, Corless CL, Nikolova Z, Dimitrijevic S, Fletcher JA (2005) Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with Imatinib: Imatinib target exploration consortium study B2225. J Clin Oncol 23:866-873
13. Mentzel T, Beham A, Katenkamp D, Dei Tos AP, Fletcher CD (1998) Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: Clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol 22:576-587
14. O'Brien KP, Seroussi E, Dal Cin P, Sciot R, Mandahl N, Fletcher JA, Turc-Carel C, Dumanski JP (1998) Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer 23:187-193
15. Shimizu A, O'Brien KP, Sjoblom T, Pietras K, Buchdunger E, Collins VP, Heldin CH, Dumanski JP, Ostman A (1999) The dermatofibrosarcoma protuberans associated collagen type Ia1/plateletderived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB Cancer Res 59:3719-3723
16. Sirvent N, Maire G, Pedeutour F (2003) Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosom Cancer 37:1-19
17. Sjöblom T, Shimizu A, O'Brien KP, Pietras K, Dal Cin P, Buchdunger E, Dumanski JP, Ostman A, Heldin CH (2001) Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist ST1571 through induction of apoptosis. Cancer Res 61:5778-5783
18. Sun LM, Wang CJ, Huang CC, Leung SW, Chen HC, Fang FM, Huang EY, Lee SP (2000) Dermatofibrosarcoma protuberans: Treatment results of 35 cases. Radiother Oncol 57:175-181
19. Takahira T, Oda Y, Tamiya S, Higaki K, Yamamoto H, Kobayashi C, Izumi T, Tateishi N, Iwamoto Y, Tsuneyoshi M (2007) Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans. Mod Pathol 20:668-675
20. Ugurel S, Utikal J, Mohr P, Helmbold C, Pfoehler C, Schiller M, Kellner I, Schadendorf D (2006) Imatinib in locally advanced dermatofibrosarcoma protuberans (DFSP): A phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG). J Clin Oncol ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement):9561